Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Novartis Pharmaceuticals
- Study ID
- NCT01731990
- Phase
- PHASE2
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Canakinumab (ACZ885) — DRUGDosage form: solution for injection Strength: 150 mg/1 mL Mode of administration: subcutaneous use.
- Placebo — DRUGMatching placebo of Canakinumab
Study Details
This study was designed to assess the safety, tolerability and efficacy of ACZ885 on the leg artery structure and physical activity in patients with atherosclerotic peripheral artery disease and leg pain from walking.
Key Dates
- Start date
- Oct 30, 2012
- Status verified
- Apr 2025
- Primary completion
- Aug 4, 2016
- Completion
- Aug 4, 2016
Study Design
- Enrollment
- 38 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Canakinumab (ACZ885)Monthly subcutaneous doses of Canakinumab 150 mg/1 mL for 12 months
- Placebo Comparator: PlaceboMonthly subcutaneous doses of placebo of Canakinumab 150 mg/1 mL for 12 months
Primary Outcome Measure
Mean Vessel Wall Area Ratio of 12 Months to Baseline [ Time Frame: Baseline, 12 months post-dose ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Novartis Investigative Site | Phoenix | Arizona | 85302 | - |
| Novartis Investigative Site | Jacksonville | Florida | 32207 | - |
| Novartis Investigative Site | Jacksonville | Florida | 32216 | - |
| Novartis Investigative Site | Chicago | Illinois | 60611 | - |
| Novartis Investigative Site | Lutherville | Maryland | 21093 | - |
| Novartis Investigative Site | Columbus | Ohio | 43215 | - |
| Novartis Investigative Site | Knoxville | Tennessee | 37920 | - |
| Novartis Investigative Site | Richmond | Virginia | 23294 | - |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio
- Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb AmputationRecruiting · VA Office of Research and Development · Aurora, Colorado
- Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility LossRecruiting · Northwestern University · Chicago, Illinois
- The COCOA-PAD II TrialPHASE3 · Recruiting · Northwestern University · Chicago, Illinois